Shanghai Fudan Forward S&T Co., Ltd

600624

CNE0000006S1

Pharmaceuticals

End-of-day quote Shanghai S.E. Other stock markets 06:00:00 2024-04-29 pm EDT			5-day change	1st Jan Change
4.11 ^CNY	-3.07%		+1.48%	-28.02%

Apr. 29	Shanghai Fudan Forward S&T Co., Ltd Reports Earnings Results for the First Quarter Ended March 31, 2024	CI
Apr. 29	Shanghai Fudan Forward S&T Co., Ltd Reports Earnings Results for the Full Year Ended December 31, 2023	CI

Tranche Update on Shanghai Fudan Forward S&T Co., Ltd's Equity Buyback Plan announced on June 30, 2021.

October 08, 2021

From June 29, 2021 to September 30, 2021, the company has repurchased 1,199,901 shares, representing 0.18% for CNY 8.42 million. With this, the company has completed the repurchase of 1,199,901 shares, representing 0.18% for CNY 8.42 million under the buyback announced on June 30, 2021.

Latest news about Shanghai Fudan Forward S&T Co., Ltd

Shanghai Fudan Forward S&T Co., Ltd Reports Earnings Results for the First Quarter Ended March 31, 2024	Apr. 29	CI
Shanghai Fudan Forward S&T Co., Ltd Reports Earnings Results for the Full Year Ended December 31, 2023	Apr. 29	CI
Shanghai Fudan Forward S&T Co., Ltd Reports Earnings Results for the Nine Months Ended September 30, 2023	23-10-27	CI
Fudan Forward S&T to Auction Office Property For At Least 31 Million Yuan	23-10-12	MT
Fudan Forward S&T Chairman Retires	23-09-29	MT
Shanghai Fudan Forward S&T Co., Ltd Reports Earnings Results for the Half Year Ended June 30, 2023	23-08-30	CI
Shanghai Fudan Forward S&T Co., Ltd Reports Earnings Results for the First Quarter Ended March 31, 2023	23-04-28	CI
Shanghai Fudan Forward S&T Co., Ltd Reports Earnings Results for the Full Year Ended December 31, 2022	23-04-28	CI
Shanghai Fudan Forward S&T Co., Ltd Reports Earnings Results for the Nine Months Ended September 30, 2022	22-10-28	CI
Shanghai Fudan Forward S&T Co., Ltd Reports Earnings Results for the Half Year Ended June 30, 2022	22-08-26	CI
Shanghai Fudan Forward S&T Co., Ltd Reports Earnings Results for the First Quarter Ended March 31, 2022	22-04-29	CI
Tranche Update on Shanghai Fudan Forward S&T Co., Ltd's Equity Buyback Plan announced on June 30, 2021.	22-03-31	CI
Shanghai Fudan Forward S&T Co., Ltd's Equity Buyback announced on June 30, 2021, has expired with 5,365,068 shares, representing 0.78% for CNY 35.01 million.	22-03-29	CI
Tranche Update on Shanghai Fudan Forward S&T Co., Ltd's Equity Buyback Plan announced on June 30, 2021.	22-01-04	CI
Shanghai Fudan Forward S&T Co., Ltd Reports Earnings Results for the Nine Months Ended September 30, 2021	21-10-29	CI
Tranche Update on Shanghai Fudan Forward S&T Co., Ltd's Equity Buyback Plan announced on June 30, 2021.	21-10-08	CI
Shanghai Fudan Forward S&T Co., Ltd Reports Earnings Results for the Half Year Ended June 30, 2021	21-08-27	CI
Shanghai Fudan Forward S&T Co., Ltd commences an Equity Buyback Plan for CNY 70 million worth of its shares, under the authorization approved on April 8, 2021.	21-06-29	CI
Shanghai Fudan Forward S&T Co., Ltd Reports Earnings Results for the First Quarter Ended March 31, 2021	21-04-29	CI
Shanghai Fudan Forward S&T Co., Ltd Reports Earnings Results for the Full Year Ended December 31, 2020	21-04-29	CI
Shanghai Fudan Forward S&T Co., Ltd Reports Earnings Results for the Nine Months Ended September 30, 2020	20-10-30	CI
Shanghai Fengxian Investment Co., Ltd. completed the acquisition of 10% stake in Shanghai Fudan Forward Pharmaceutical Co., Ltd. from Shanghai Fudan Forward S&T Co., Ltd	20-09-22	CI
Shanghai Fengxian Investment Co., Ltd., completed the acquisition of 18.74% stake in Shanghai Fudan Forward S&T Co., Ltd from Fudan University, Endowment Arm.	20-09-03	CI
Shanghai Fudan Forward S&T Co., Ltd Reports Earnings Results for the Half Year Ended June 30, 2020	20-08-21	CI
Shanghai Fudan Forward S&T Co., Ltd Announces Tax Included Final Cash Dividend for the Full Year of 2019, Payable on August 03, 2020	20-07-22	CI

Chart Shanghai Fudan Forward S&T Co., Ltd

Duration

Period

Chart Shanghai Fudan Forward S&T Co., Ltd

More charts

Company Profile

SHANGHAI FUDAN FORWARD S&T CO., LTD is a China-based company, principally engaged in the manufacture and distribution of pharmaceuticals. The Company's pharmaceuticals include digestive system drugs, nervous system drugs, antineoplastic drugs, circulatory drugs, immune function medications and others. The Company is also engaged in the provision of financial insurance software products. It distributes its products within domestic markets and to overseas markets.

Sector

Pharmaceuticals

Calendar

2024-06-05 - Annual General Meeting

More about the company

Income Statement Evolution

More financial data

Sector Generic Pharmaceuticals

	1st Jan change	Capi.
SHANGHAI FUDAN FORWARD S&T CO., LTD	-28.02%	386M
SUN PHARMACEUTICAL INDUSTRIES LTD.	+21.41%	43.48B
OTSUKA HOLDINGS CO., LTD.	+20.67%	22.65B
SANDOZ GROUP AG	+14.60%	14.73B
CIPLA LIMITED	+14.21%	13.79B
ZYDUS LIFESCIENCES LIMITED	+48.11%	12.04B
ONO PHARMACEUTICAL CO., LTD.	-8.37%	7.08B
THE MEDICINES COMPANY	-0.05%	6.79B
STADA ARZNEIMITTEL	-8.87%	5.73B
ASPEN PHARMACARE HOLDINGS LIMITED	+11.90%	5.47B

Generic Pharmaceuticals

Shanghai Fudan Forward S&T Co., Ltd

Equities

600624

CNE0000006S1

Pharmaceuticals

Tranche Update on Shanghai Fudan Forward S&T Co., Ltd's Equity Buyback Plan announced on June 30, 2021.

Latest news about Shanghai Fudan Forward S&T Co., Ltd

Chart Shanghai Fudan Forward S&T Co., Ltd

Company Profile

Income Statement Evolution

Sector Generic Pharmaceuticals